Director, Metabolic Bone Disease Program
NYU Langone Health System | |
United States, New York, New York | |
Feb 04, 2026 | |
|
The Division of Endocrinology, Diabetes and Metabolism at NYU Langone Health invites applications for the position of Director of the Metabolic Bone Disease Program. This is a leadership role for a clinician with recognized expertise in bone and mineral metabolism who will oversee and expand a comprehensive, system wide program focused on osteoporosis and related skeletal disorders. Under the direction of the Division Director, the Director of the Metabolic Bone Disease Program will provide clinical, programmatic, and strategic leadership for bone health services across NYU Langone Health. The successful candidate will play a central role in advancing high quality, evidence-based care, strengthening multidisciplinary collaboration, and building a sustainable and nationally visible metabolic bone program. Clinical Responsibilities Program Leadership and Strategic Development The Director will be expected to initiate and lead clinical research in metabolic bone disease, including investigator initiated and/or industry sponsored clinical trials. This includes identifying novel therapeutic and implementation focused research opportunities, overseeing study development and regulatory submissions, and integrating clinical trials into routine bone health practice across the NYU Langone network. The Director will work closely with Endocrinology, Rheumatology, Radiology, Internal Medicine, Orthopedics, Geriatrics, Oncology, and other clinical partners to build coordinated, multidisciplinary pathways for patients with complex skeletal disease, and to leverage these collaborations to support patient recruitment and translational research efforts. Academic Environment Why NYU Langone NYU Langone Health is consistently ranked among the top hospitals in the nation, with internationally recognized programs in diabetes, obesity, lipid disorders, and cancer metabolism. The Division offers robust clinical infrastructure, strong support for research operations, access to large and diverse patient populations, and leadership opportunities across NYULH campuses. Salary Range: $250,000-$250,000 The salary range listed is for full-time employment and does not include incentive compensation or benefits. Actual salary may not fall within the listed salary range; consideration will be made for experience, training, hospital/community need, and other factors. Applicants must hold an MD or MD PhD, be board certified in Endocrinology, Diabetes and Metabolism, and be eligible for medical licensure in New York State. Candidates should demonstrate established expertise in metabolic bone disease and a strong commitment to clinical excellence, program development, and multidisciplinary collaboration. Competitive candidates will have national visibility in bone metabolism or osteoporosis and or a demonstrated track record of leading multicenter or nationally recognized clinical trials in this area. Academic rank will be commensurate with experience and scholarly accomplishments. NYU Langone Healthis an equal opportunity employer and committed to inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration. | |
Feb 04, 2026